Medical News

RSS

Shire announces the Canadian availability of VYVANSE prodrug therapy for ADHD treatment

Canadian families managing Attention Deficit Hyperactivity Disorder (ADHD) have a new treatment option. Today, Shire plc, the global specialty biopharmaceutical company, announced the Canadian availability of VYVANSE (lisdexamfetamine dimesylate capsule), the first and only prodrug therapy approved for ADHD treatment in Canada.

2 Feb 2010

U.N. Secretary-General focuses on MDGs during African Union Summit

Addressing the 14th African Union (AU) Summit on Sunday, U.N. Secretary-General Ban Ki-moon called for African countries to maintain their commitment to the Millennium Development Goals (MDGs), "which include reducing poverty, disease and child mortality, ahead of their target date of 2015," BBC reports (1/31).

2 Feb 2010

DATATRAK International announces multi-center study on Renal Anemia

DATATRAK International, Inc., a technology and services company focused on global eClinical solutions for the clinical trials industry, today announced the contract signing for a Phase IV, eight-year, 500-site, 5,000-patient study worth approximately $900,000 with a global specialty pharmaceutical and medication delivery company.

2 Feb 2010

Australian TGA approves IDSI's CT Laser Mammography system for inclusion on ARTG

Imaging Diagnostic Systems, Inc., a pioneer in laser optical breast imaging, announced today that the Australian Government Department of Health and Ageing Therapeutic Goods Administration has approved the CT Laser Mammography (CTLM®) system for inclusion on the Australian Register of Therapeutic Goods (ARTG).

2 Feb 2010

Cellectricon resumes litigation against Fluxion Biosciences over alleged patent infringement

Cellectricon AB today announced that it has resumed its litigation against Fluxion Biosciences, Inc. Cellectricon filed the lawsuit in July 2009 in the United States District Court for the Northern District of California alleging infringement of several United States patents issued or licensed to Cellectricon for microfluidic technology used in Cellectricon's state-of-the-art ion channel drug screening solution, the Dynaflow(R)HT System. Cellectricon's U.S. Patents Nos. 7,390,650, 7,470,518 and 7,563,614 have been asserted in the litigation, as well as U.S. Patent No. 5,376,252, which is owned by Gyros, and licensed to Cellectricon.

From Fluxion Biosciences 2 Feb 2010

More details on Obama's global health strategy expected along with budget release, Wall Street Journal reports

"The Obama administration is expected to propose in its fiscal 2011 budget Monday new funding to combat preventable and tropical diseases, malnutrition and other conditions afflicting the world's poor, as part of a strategy to broaden its approach to global health," the Wall Street Journal reports.

2 Feb 2010

Experimental vaccine reduced TB rate among HIV-positive people in Tanzania, Study finds

An experimental vaccine was found to reduce the rate of tuberculosis infections in patients living with HIV, "the first time a shot has been shown to reduce cases of the most common AIDS-related cause of death in poor nations," Bloomberg reports (Bennett, 1/29). Tuberculosis accounts for up to one-third of AIDS deaths worldwide, CBC News reports.

1 Feb 2010

Study: Schizophrenia patients may experience beneficial brain changes in response to exercise

Potentially beneficial brain changes (an increase in the volume of an area known as the hippocampus) occur in response to exercise both in patients with schizophrenia and healthy controls, according to a report in the February issue of Archives of General Psychiatry, one of the JAMA/Archives journals.

1 Feb 2010

Health and Human Services would get boost under Obama's 2011 budget plan

News outlets report on how Health and Human Services fares under Obama's 2011 budget request.

1 Feb 2010

TOPICA's IND for onychomycosis antifungal agent accepted by FDA

TOPICA Pharmaceuticals, a privately-held biotechnology company, today announced that the U.S. Food and Drug Administration (FDA) has accepted the company's Investigational New Drug (IND) application for the use of luliconazole, its lead product candidate, in patients with onychomycosis (nail and nail bed fungal infections).

1 Feb 2010

Romark Laboratories commences enrollment in Alinia clinical trial for acute uncomplicated influenza

Romark Laboratories announced that it has initiated enrollment of patients in a clinical trial of Alinia® (nitazoxanide) for treating acute uncomplicated influenza including illness caused by the currently circulating H1N1 strain.

1 Feb 2010

Florida scholars criticize media coverage of health reform

Journalism researchers criticized media coverage of the health care bills saying it may have added to consumers' confusion, Health News Florida reports. "Very little broadcast time or print space has been devoted to explaining, point-by-point, the major parts of the legislation, say three top researchers in the field from University of Florida, Florida State University and University of South Florida.

1 Feb 2010

Ecolab launches EnCompass Environmental Hygiene program to improve patient room hygiene

Ecolab Inc. today announced the launch of its new EnCompass™ Environmental Hygiene program, a comprehensive clinical program that helps hospitals improve patient room hygiene and prevent the spread of infections.

1 Feb 2010

Researchers design bioactive nanomaterial that promotes cartilage growth

Northwestern University researchers are the first to design a bioactive nanomaterial that promotes the growth of new cartilage in vivo and without the use of expensive growth factors. Minimally invasive, the therapy activates the bone marrow stem cells and produces natural cartilage.

1 Feb 2010

YM BioSciences-Cytopia merger complete

YM BioSciences Inc., announced that the merger of Cytopia Limited, the Australian biopharmaceutical company, into YM under a Scheme of Arrangement, has been concluded.

1 Feb 2010

Cordis, Boston Scientific agree to resolve two Delaware litigations related to coronary stent patents

Cordis Corporation, a Johnson & Johnson company, announced today that it has reached an agreement with Boston Scientific resolving two Delaware litigations related to Cordis's Palmaz and Gray patents and Boston Scientific's Jang patents.

1 Feb 2010

Congressional leader stresses the importance of annual dilated eye exam for diabetes patients

In recognition of Black History Month, House Majority Whip James E. Clyburn is urging African Americans with diabetes to get an annual diabetic eye exam during February.

1 Feb 2010

Survey: Medicaid beats private insurance when it comes to prevention

Sen. Lamar Alexander - as well as other conservative lawmakers - characterized Medicaid as a "medical ghetto" during Senate floor speeches on the health overhaul debate last year, American Medical News reports. But, the 2007 National Survey of Children's Health contradicts that common perception. "Based on nearly 92,000 interviews, it found that in 36 states, children in Medicaid and CHIP were as likely or more likely than privately insured kids to have had at least one preventive health care visit over a 12-month period."

1 Feb 2010

University of Pittsburgh awarded $3.5M NIH grant for WaferGen Biosystems's SmartChip Real-Time PCR System

WaferGen Biosystems, Inc., a leading developer of state-of-the-art genetic analysis systems, today announced that the National Institutes of Health (NIH) awarded a grant to the University of Pittsburgh that includes funding of $350,000 over the grant period for WaferGen's SmartChip™ Real-Time PCR System. The researchers will conduct novel gene expression research in the areas of advanced lung disease and asthma and will use the SmartChip system as the key platform for high throughput validation.

1 Feb 2010

BioBehavioral Diagnostics completes $10M Series B financing round

BioBehavioral Diagnostics (BioBDx), a privately held company which manufactures and markets the Quotient™ ADHD System, a tool that aids in the objective and accurate assessment of attention-deficit hyperactivity disorder (ADHD), announced today the first close of a $10 million Series B financing.

1 Feb 2010

Medical News

Shire announces the Canadian availability of VYVANSE prodrug therapy for ADHD treatment

U.N. Secretary-General focuses on MDGs during African Union Summit

DATATRAK International announces multi-center study on Renal Anemia

Australian TGA approves IDSI's CT Laser Mammography system for inclusion on ARTG

Cellectricon resumes litigation against Fluxion Biosciences over alleged patent infringement

More details on Obama's global health strategy expected along with budget release, Wall Street Journal reports

Experimental vaccine reduced TB rate among HIV-positive people in Tanzania, Study finds

Study: Schizophrenia patients may experience beneficial brain changes in response to exercise

Health and Human Services would get boost under Obama's 2011 budget plan

TOPICA's IND for onychomycosis antifungal agent accepted by FDA

Romark Laboratories commences enrollment in Alinia clinical trial for acute uncomplicated influenza

Florida scholars criticize media coverage of health reform

Ecolab launches EnCompass Environmental Hygiene program to improve patient room hygiene

Researchers design bioactive nanomaterial that promotes cartilage growth

YM BioSciences-Cytopia merger complete

Cordis, Boston Scientific agree to resolve two Delaware litigations related to coronary stent patents

Congressional leader stresses the importance of annual dilated eye exam for diabetes patients

Survey: Medicaid beats private insurance when it comes to prevention

University of Pittsburgh awarded $3.5M NIH grant for WaferGen Biosystems's SmartChip Real-Time PCR System

BioBehavioral Diagnostics completes $10M Series B financing round

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News